Although genetic and epigenetic changes activate Wnt/β-catenin signaling to drive the progression of prostate cancer [235], it is not commonly observed for CTNNB1, APC, and AXIN1 genes to undergo mutations in prostate cancer [236]. The gene discussed is APC; the disease is prostate carcinoma.